Japanese

You have access
Risk Factors for Niraparib-induced Severe Anemia in Japanese Patients With Ovarian Cancer: A Multicenter Study
YUKI OZAWA, HIROMU TANIGAWA, TATSUHIRO FUJIMIYA, YOSHIKI ABE, JOH HIROHARA, MARII SUEHIRO, YUKI TANAKA, NAOKI SHIBATA, TAKASHI YOKOKAWA, JUNICHI KUSANO, TORU ARASE and TAKUMA KOINUMA

Anticancer Research May 2026, 46 (5) 2887-2897; DOI: https://doi.org/10.21873/anticanres.18167
Open Access
Feasibility of Near-infrared Photoimmunotherapy Combined With Immune Checkpoint Inhibitor Therapy in Unresectable Head and Neck Cancer
HITOSHI HIRAKAWA, TARO IKEGAMI, HIDETOSHI KINJYO, YOSHIKAZU HAYASHI, SHINYA AGENA, TERUYUKI HIGA, SHUNSUKE KONDO, MASATOMO TOYAMA, HIROYUKI MAEDA and MIKIO SUZUKI

Anticancer Research September 2024, 44 (9) 3907-3912; DOI: https://doi.org/10.21873/anticanres.17218
You have access
Optimal Treatment of Hormone Receptor-positive Advanced Breast Cancer Patients With Palbociclib
MIDORI MORITA, ASAKO OOE, WATARU ISHII, AKIRA WATANABE, CHISE MATSUI, YUKA OKUYAMA, SAE KITANO, CHIKAGE KATO, MIE ONISHI, KOICHI SAKAGUCHI and YASUTO NAOI

Anticancer Research June 2023, 43 (6) 2783-2789; DOI: https://doi.org/10.21873/anticanres.16447
You have access
Impact of Concomitant Use of Azoles on Bortezomib-related Adverse Drug Reactions Using JADER
TAKUYA IMATOH, TAICHI MATSUMOTO, YUTAKA HARAMAKI and KEISUKE MIGITA

Anticancer Research March 2023, 43 (3) 1341-1349; DOI: https://doi.org/10.21873/anticanres.16282
You have access
Induction Chemotherapy in Hypopharyngeal Cancer: Influence of DNA Repair Gene Polymorphisms
HITOSHI HIRAKAWA, TARO IKEGAMI, SATOE AZECHI, SHINYA AGENA, JIN UEZATO, HIDETOSHI KINJYO, YUKASHI YAMASHITA, ASANORI KIYUNA, KATSUNORI TANAKA, SHUNSUKE KONDO, HIROYUKI MAEDA, MIKIO SUZUKI and AKIRA GANAHA

Anticancer Research June 2020, 40 (6) 3277-3285; DOI: https://doi.org/10.21873/anticanres.14310
You have access
Telomere Length in Leukocyte DNA in Gastric Cancer Patients and its Association with Clinicopathological Features and Prognosis
TOMOMITSU TAHARA, SAYUMI TAHARA, NORIYUKI HORIGUCHI, TOMOHIKO KAWAMURA, MASAAKI OKUBO, TAKAMITSU ISHIZUKA, HYUGA YAMADA, DAI YOSHIDA, TAKAFUMI OHMORI, KOHEI MAEDA, NARUOMI KOMURA, HIROKAZU IKUNO, YASUTAKA JODAI, TOSHIAKI KAMANO, MITSUO NAGASAKA, YOSHIHITO NAKAGAWA, TETSUYA TUSKAMOTO, MAKOTO URANO, TOMOYUKI SHIBATA, MAKOTO KURODA and NAOKI OHMIYA

Anticancer Research April 2017, 37 (4) 1997-2001;
You have access
Multicenter Phase II Study of Second-line Cetuximab plus Folinic Acid/5-Fluorouracil/Irinotecan (FOLFIRI) in KRAS Wild-type Metastatic Colorectal Cancer: The FLIER Study
SHIGEYOSHI IWAMOTO, SHOICHI HAZAMA, TAKESHI KATO, YASUHIRO MIYAKE, MUTSUMI FUKUNAGA, CHU MATSUDA, HIROYUKI BANDO, JUNICHI SAKAMOTO, KOJI OBA and HIDEYUKI MISHIMA

Anticancer Research April 2014, 34 (4) 1967-1973;
You have access
Pemetrexed and Cisplatin for Advanced Non-squamous Non-small Cell Lung Cancer in Japanese Patients: Phase II Study
YUKO KAWANO, FUMIYOSHI OHYANAGI, NORIKO YANAGITANI, KEITA KUDO, ATSUSHI HORIIKE, AZUSA TANIMOTO, HIRONARI NISHIZAWA, ATSUO ICHIKAWA, TOSHIO SAKATANI, KATSUMI NAKATOMI, SACHIKO HAGIWARA, HIRONORI NINOMIYA, NORIKO MOTOI, YUICHI ISHIKAWA, TAKESHI HORAI and MAKOTO NISHIO

Anticancer Research August 2013, 33 (8) 3327-3333;

Main menu

User menu

Search

Japanese